A phase 1 trial evaluating chimeric antigen receptor (CAR)-T cell targeting an aggressive brain cancer: malignant glioma including glioblastoma in adults and children

Trial Profile

A phase 1 trial evaluating chimeric antigen receptor (CAR)-T cell targeting an aggressive brain cancer: malignant glioma including glioblastoma in adults and children

Planning
Phase of Trial: Phase I

Latest Information Update: 11 Oct 2017

At a glance

  • Drugs MB 101 (Primary)
  • Indications Glioblastoma; Glioma
  • Focus Adverse reactions
  • Most Recent Events

    • 11 Oct 2017 New trial record
    • 04 Oct 2017 According to a City of Hope media release, this trial has received grant from the California Institute for Regenerative Medicine (CIRM).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top